Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 21 results found. Search for [ anti-AIDS drugs ]

Results 1 to 21 of 21
E Kumar Sharma
New Delhi, July 18, 2018
Those within the pharma industry see a couple of messages coming across from the movie.

E Kumar Sharma
May 27, 2015
Mylan is strongly resisting an unsolicited $40 billion bid by Israel-based Teva to acquire Mylan. But on the other hand, it is also pursuing its own $32.7 billion bid to acquire Ireland-based maker of cough and cold remedies.

E Kumar Sharma
November 21, 2014
API manufacturer Laurus Labs believes in excelling in its chosen segments, not in following trends.

E Kumar Sharma
October 31, 2014
Speaking to Business Today, Cipla Chairman YK Hamied says he is increasingly getting convinced that Ebola is an offshoot of HIV.

E. Kumar Sharma
June 19, 2014
Experts says consolidation, which may well have major implications, is inevitable in Indian pharma. Market watchers say that among the major Indian pharma companies the two most prized pickings would be Dr. Reddy's Laboratories and Cipla Ltd.

New Delhi, May 3, 2014
\"India is not just contributing to the arena of medicines but also playing a humanitarian role by manufacturing medicines and supplying them at a low cost across the world,\" Hamied said.

E Kumar Sharma
April 29, 2014
Cipla, whose chairman Yusuf Khwaja Hamied, jolted the global pharma industry in 2001 with his offer to sell anti-AIDS drugs at less than 4 per cent of the price charged by international drugmakers, in January this year got a notice for overcharging for some medicines in India.

New Delhi, March 10, 2014
\"87 developing nations, their entire health care system is supported by Indian medicines, and we're committed to ensure that even the new generation of life-saving drugs, the Indian pharmaceutical industry will make, are available to our people and people of developing countries,\" Commerce Minister Anand Sharma said.

E. Kumar Sharma
February 12, 2014
Dr Peter Mugyenyi, author of Genocide by Denial: How Profiteering from HIV/AIDS Killed Millions (2008) has joined the board of Cipla as an independent director.

Chaitanya Kalbag
May 8, 2013
It turns out that India is crawling with thousands of chit funds and other dubious deposit-taking rackets, and cheat shops emerge from the shadows in examples like the 130 Kerala chit funds that set up office in one building in the industrial town of Faridabad in Haryana.

E. Kumar Sharma
May 9, 2013
Y.K. Hamied steps down as managing director of Cipla in February. His decision to function as non-executive chairman from April 1 and other management changes are significant. The move is part of a major transformation aimed at propelling the company into a new orbit.

E. Kumar Sharma
November 23, 2012
The deal, when concluded, will give Cipla more access to the region and a direct, customer-facing presence in a key export market. Medpro would be the biggest international acquisition by the company, though not the first - officials confirm that its already has stakes in some foreign companies.
June 7, 2012
Starring: J.S. Sarma, Rahul Khullar, Dev Amritesh, Y.K. Hamied, Hiroyuki Suzuki, Pallavi Jha

E Kumar Sharma
Hyderabad, May 4, 2012
Cipla says that its decision to slash prices of cancer drugs is purely a humanitarian gesture. In cancer treatment, it is planning to do what it did in anti-AIDS drugs many years ago by launching them at low prices.

E Kumar Sharma
August 3, 2011
He may be an NRI who spends half the year abroad, but Cipla's Chairman Yusuf Khwaja Hamied, 74, tracks developments in India and in his company every minute, while also keeping himself abreast of global scientific developments and market trends. He spoke to BT from Spain on his vision for Cipla. Edited excerpts:

E. Kumar Sharma
August 18, 2011
At 75, Cipla is in fine fettle but its chairman faces challenges that are very different from those of the past.

New Delhi, December 20, 2010
The 913.5-million rand order bagged by Sonke Pharmaceuticals is a part of a 4.28 billion rand national anti-retroviral (ARV) tender floated by the African government.

E. Kumar Sharma
October 9, 2010
Indian pharma companies are targeting generic versions of biotech-based drugs, which can slash treatment costs for killer diseases like cancer.
June 26, 2008
The takeover of India’s best-known drug maker, Ranbaxy Laboratories, by Japanese innovator company, Daiichi Sankyo, may have evoked a sense of disbelief all around.

Pallavi Srivastava and Manu Kaushik
March 1, 2008
Small cars are in the fast lane, but mobile phones get dearer.

PAGES 1 OF 2  12